Botanix Pharmaceuticals (ASX:BOT) Reports Strong Sofdra™ Launch Performance
Sales Performance
Botanix Pharmaceuticals reported gross sales of approximately $25 million AUD for Sofdra™ since January 2025, with consistent month-over-month growth through June.
Prescriber and Prescription Growth
Over 2,300 unique prescribers wrote Sofdra™ prescriptions in June, and more than 16,000 prescriptions have been filled across 6,700 patients since launch. Refill rates exceeded the industry average, contributing to the strong prescription growth.
Strategic Investments
The company is expanding its territories from 27 to 33 in Q1 FY2026 and plans to reach 50 territories by Q2 FY2026. Additional hiring for regional managers and investments in sales and point-of-care materials are underway to accelerate growth.
Digital Presence and Education
Botanix maintains a digital presence through its telehealth platform and hosts the “Summer of Sweat” event series, engaging healthcare providers in 14 major US cities to promote Sofdra™.
Executive Comments
Executive Chairman Vince Ippolito commented: “We are pleased with the overall performance of Sofdra since its launch in February 2025. The launch trajectory of Sofdra is trending in a positive direction, and we expect continued growth.”
Motley Fool contributor Lianne Eastty has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.
This article was generated using GPT-4o mini, a Large Language Model (LLM), to generate summaries of investing news. While AI is generating the content, we know better than to blindly trust our future robot overlords, and every article is edited and fact-checked by an editor holding the appropriate credentials. The Motley Fool Australia stands behind the work of our editorial team and takes ultimate responsibility for the content of everything published by The Capital Club.
